Improving food intake in anorectic cancer patients

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 6, Issue 4, 2003, Pages 421-426

  Laviano, Alessandro ^a   Meguid, Michael M ^b   Rossi Fanelli, Filippo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Anorexia; Cancer; Cytokines; Dopamine; Hypothalamus; Melanocortins; Serotonin; Therapy

Indexed keywords

AGOUTI RELATED PROTEIN; CYTOKINE; DOPAMINE; INTERLEUKIN 1; INTERLEUKIN 6; MELANOCORTIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; SEROTONIN; TUMOR NECROSIS FACTOR;

ANOREXIA; CALORIC INTAKE; CANCER PATIENT; FOOD INTAKE; HUMAN; MEDIATOR RELEASE; MONOAMINERGIC SYSTEM; NEUROTRANSMITTER RELEASE; PROTEIN EXPRESSION; QUALITY OF LIFE; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; TARGET CELL; TERMINAL DISEASE; TUMOR GROWTH;

ANOREXIA; CYTOKINES; ENERGY INTAKE; HOMEOSTASIS; HUMANS; NEOPLASMS; NEURAL PATHWAYS; SIGNAL TRANSDUCTION;

EID: 6944237165     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200307000-00011     Document Type: Review

References (43)

1. Rossi Fanelli F, Muscaritoli M, Cangiano C, et al. The basis for a rational nutritional approach to patients with cancer. In: Abraham NG, Tabilio A, Martelli M, et al., editors. Molecular biology of hematopoiesis 6. New York: Kluwer Academic/Plenum Publishers; 1999. pp. 229-234.
2. Maltoni M, Nanni O, Pirovano M, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 1999; 17:240-247.
3. Bernstein IL. Taste aversion learning: a contemporary perspective. Nutrition 1999; 15:229-234.
4. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69:491-497.
5. Rossi Fanelli F, Cangiano C, Ceci F, et al. Plasma tryptophan and anorexia in human cancer. Eur J Cancer Clin Oncol 1986; 22:89-95.
6. Schwartz MW, Woods SC, Porte Jr D, et al. Central nervous system control of food intake. Nature 2000; 404:661-671.
7. Janik JE, Curti BD, Considine RV, et al. Interleukin-1 alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab 1997; 82:3084-3086.
8. Chance WT, Sheriff S, Moore J, et al. Reciprocal changes in hypothalamic receptor binding and circulating leptin in anorectic tumor-bearing rats. Brain Res 1998; 803:27-33.
9. Simons JP, Schols AM, Campfield LA, et al. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci 1997; 93:273-277.
10. Mantovani G, Maccio A, Mura L, et al. Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J Mol Med 2000; 78:554-561.
11. Kahler A, Zimmermann M, Langhans W. Suppression of hepatic fatty acid oxidation and food intake in men. Nutrition 1999; 15:819-828.
12. Loftus TM, Jaworsky DE, Frehywot GL, et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000; 288:2379-2381.
13. Laviano A, Meguid MM, Renvyle T, et al. Carnitine supplementation accelerates normalization of food intake depressed during TPN. Physiol Behav 1996; 60:317-320.
14. Chance WT, Balasubramaniam A, Fischer JE. Neuropeptide Y and the development of cancer anorexia. Ann Surg 1995; 221:579-587.
15. Chance WT, Sheriff S, Kasckow JW, et al. NPY messenger RNA is increased in medial hypothalamus of anorectic tumor-bearing rats. Regul Pept 1998; 75-76:347-353.
16. Plata-Salaman CR, Ilyin SE, Gayle D. Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. Am J Physiol Regul Integr Comp Physiol 1998; 275:R566-R573.
17. Marks DL, Ling N, Cone RD. Role of central melanocortin system in cachexia. Cancer Res 2001; 61:1432-1438. This paper and Ref. [18] are the first reports in the literature demonstrating that the hypothalamic melanocortin system is involved in cancer anorexia and cachexia.
18. Wisse BE, Frayo RS, Schwartz MW, Cummings DE. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 2001; 142:3292-3301. See annotation for [17].
19. Plata-Salaman CR. Anorexia during acute and chronic disease. Nutrition 1996; 12:69-78.
20. Opara EI, Laviano A, Meguid MM, Yang Z-J. Correlation between food intake and CSF IL-1α in anorectic tumor bearing rats. NeuroReport 1995; 6:750-752.
21. Laviano A, Gleason JR, Meguid MM, et al. Effects of intra-VMN mianserin and IL-1α on meal number in anorectic tumor-bearing rats. J Investig Med 2000; 48:40-48.
22. Wang W, Lonnroth C, Svanberg E, Lundholm K. Cytokine and cyclooxigenase-2 protein in brain areas of tumor-bearing mice with prostanoid-related anorexia. Cancer Res 2001; 61:4707-4715.
23. Wang W, Danielsson A, Svanberg E, Lundholm K. Lack of effects by tricyclic antidepressant and serotonin inhibitors on anorexia in MCG 101 tumor bearing mice with eicosanoid-related anorexia. Nutrition 2003; 19:47-53.
24. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 1999; 59:4493-4501.
25. Heisler LK, Cowley MA, Tecott LH, et al. Activation of central melanocortin pathways by fenfluramine. Science 2002; 297:609-611. An elegant study demonstrating that serotonin activates the melanocortin system in the hypothalamus.
26. Shintani F, Kanba S, Nakaki T, et al. Interleukin-1beta augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus. J Neurosci 1993; 13:3574-3581.
27. Torelli GF, Meguid MM, Moldawer LL, et al. Use of recombinant human soluble TNF receptor in anorectic tumor-bearing rats. Am J Physiol Regul Integr Comp Physiol 1999; 277:R850-R855.
28. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002; 52:72-91.
29. Mantovani G, Maccio A, Lai P, et al. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms. Crit Rev Oncog 1998; 9:99-106.
30. Jatoi A, Yamashita J, Sloan JA, et al. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer 2002; 10:71-75. A recent and interesting paper challenging some of the conclusions of Ref. [29].
31. McCarthy HD, Crowder RE, Dryden S, Williams G. Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neurpoeptide Y concentrations. Eur J Pharmacol 1994; 265:99-102.
32. Klein TW, Lane B, Newton CA, Friedman H. The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 2000; 225:1-8.
33. Srivastava MD, Srivastava BI, Brouhard B. Delta9-tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 1998; 40:179-185.
34. Jatoi A, Windschitl HE, Loprinzi CL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 2002; 20:567-573.
35. Muscaritoli M, Meguid MM, Beverly JL, et al. Mechanism of early tumor anorexia. J Surg Res 1996; 60:389-397.
36. Blaha V, Yang ZJ, Meguid MM, et al. Ventromedial nucleus of hypothalamus is related to the development of cancer-induced anorexia: in vivo microdialysis study. Acta Medica (Hradec Kralove) 1998; 41:3-11.
37. Cangiano C, Laviano A, Meguid MM, et al. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. J Natl Cancer Inst 1996; 88:550-552.
38. Herreros R, Serrat I, Boronat A. L-DOPA and cancer anorexia. Palliat Med 1999; 13:83-84.
39. Lozano RH, Jofre IS. Novel use of L-DOPA in the treatment of anorexia and asthenia associated with cancer. Palliat Med 2002; 16:548.
40. Cahlin C, Gelin J, Delbro D, et al. Effect of cyclooxigenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cachexia related to prostanoids. Cancer Res 2000; 60:1742-1749.
41. Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994; 54:5602-5606.
42. Squadrito F, Calapai G, Altavilla D, et al. Central serotoninergic system involvement in the anorexia induced by NG-nitro-L-arginine, an inhibitor of nitric oxide synthase. Eur J Pharmacol 1994; 255:51-55.
43. Lugarini F, Hrupka BJ, Schwartz GJ, et al. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am J Phyisiol Regul Integr Comp Physiol 2002; 283:R862-R868.